With its headquarters in New York and presence in London, in Athens and in Oslo, Capital Link (www.capitallink.com) has been active since 1995 in the field of Investor Relations and Financial Communication.
It also organizes annually in New York, London, Athens and Shanghai a series of Investment Forums focusing on its main activity fields (www.capitallinkforum.com).
Capital Link has a leading position globally in the area of Investor Relations with respect to shipping, as it cooperates with 25 shipping companies listed on the two US Stock Exchanges, as well as in London (LSE and AIM) and Milan. It also maintains a shipping portal with information on all UK and US Listed shipping Companies (www.capitallinkshipping.com).
Capital Link’s efforts have been recognized by the 2011 Greek Shipping Lloyds Awards and in 2012 & in 2013 by the Intercontinental Finance Magazine in London. Mr. Nicolas Bornozis has been personally honored for his relentless, efficient and highly effective efforts to promote Greece and Greek Shipping abroad and among the international investment community by the International Propeller Club of the United States and the AHI-American Hellenic Institute (http://greece.capitallink.com/ahi/videos.php).
Pathways is a health technologies company described at www.pathwaysgroup.com. The company was established in 1989 as a healthcare organization specialized in neuromedicine (neuropsychiatry and neuroendocrinology) plus preventive medicine, health policy, and management.
The company is a network of more than 100 professionals and corporate affiliates that provides healthcare management services, personal health training, business human assets management, health knowledge management technologies (multi-channel communications, mobile medical practice, integrated health databases, and anytime-anyplace personal health solutions), and health technology research.
Skyline Ventures, formed in 1997, is a nationally-known venture capital firm that specializes in investing in outstanding product-focused healthcare companies. Our areas of expertise include small molecule and protein therapeutics; medical devices; diagnostics; and technologies that facilitate drug discovery and life science research.